Page 62 - Glass Machinery Plants & Accessories no. 4-2021
P. 62
COUNTRY STUDY
Country study
DAIWA SPECIAL GLASS now company’s main factory cines. Here, expansion in Asia
COMPANY that produces most of the prod- strengthens the unique market
Niitaka Factory, which is ucts . In February 2008, the positioning that Ompi already
adjacent to the company’s head company started operations and enjoys within the sterile glass
office, is one of the company’s started production of tube bot- primary packaging market after
two production facilities. Since tles. Under a manufacturing the launch of its RTU product
its operation, it has consist- environment that incorporates portfolio in 2007.
ently produced ampoules and the idea of GMP, Daiwa Special “Ompi’s presence in Japan
tube bottles for injections and Glass has built a production will be essential in respond-
its technological accumulation line that pursues thorough ing to the highly-demanding
for more than half a century is automation and efficiency while requirements of the Japanese
still continuing. In addition, the stably producing high-quality pharmaceutical industry that
company meets cleaning bottle tube bottles. have always challenged glass
and surface treatment needs, primary packaging manufactur-
such as silicone coating and STEVANATO GROUP ers to provide innovative and
sulfur treatment. In 2009, the In 2018, Stevanato Group high-quality containers.” says
company obtained permission -through its specialist in glass Andrea Zambon, President of
for the pharmaceutical man- primary packaging for the Ompi Japan. “Ompi wants to
ufacturing industry and the pharmaceutical industry Ompi- be closer to its clients and to
medical device manufacturing opened a commercial office in become the preferred partner
industry (packaging, labeling Nagoya, Japan. Ompi provides for pharmaceutical companies
and storage), and in order to be a wide range of glass primary - not only for generic drugs,
contracted by a pharmaceuti- packaging solutions ranging which the Japanese government
®
cal company it refurbished the from bulk to EZ-fill sterile is looking to increase, but also
Niitaka factory. solutions to analytical consul- for biologic drugs that are likely
Since 2008, the production tancy aimed at guaranteeing the to experience some fast growth
line for tube bottles has been integrity of parenteral medi- over the coming years.” O
relocated to Ichishima and is
60 GMP&A 4/2022
